{
    "id": 10099,
    "fullName": "NFE2L2 T80R",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "NFE2L2 T80R lies within the ETGE motif in the Keap1 binding domain of the Nfe2l2 protein (PMID: 18757741). T80R confers a gain of function to the NFE2L2 protein, as demonstrated by decreased Nfe2l2 association with Keap1, accumulation of Nfe2l2, increased activation of Nfe2l2 target genes (PMID: 29018201), and is transforming in cell culture (PMID: 18757741, PMID: 21062981).",
            "references": [
                {
                    "id": 3399,
                    "pubMedId": 18757741,
                    "title": "Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/18757741"
                },
                {
                    "id": 15273,
                    "pubMedId": 29018201,
                    "title": "Activating de novo mutations in NFE2L2 encoding NRF2 cause a multisystem disorder.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/29018201"
                },
                {
                    "id": 3400,
                    "pubMedId": 21062981,
                    "title": "Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21062981"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4780,
        "geneSymbol": "NFE2L2",
        "terms": [
            "NFE2L2",
            "HEBP1",
            "IMDDHH",
            "Nrf-2",
            "NRF2"
        ]
    },
    "variant": "T80R",
    "createDate": "08/05/2015",
    "updateDate": "06/06/2019",
    "referenceTranscriptCoordinates": {
        "id": 133975,
        "transcript": "NM_006164",
        "gDna": "chr2:g.177234078G>C",
        "cDna": "c.239C>G",
        "protein": "p.T80R",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 2687,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, Sirolimus (rapamycin) inhibited proliferation of transformed cells expressing NFE2L2 T80R in culture (PMID: 21062981).",
            "molecularProfile": {
                "id": 10103,
                "profileName": "NFE2L2 T80R"
            },
            "therapy": {
                "id": 917,
                "therapyName": "Sirolimus",
                "synonyms": null
            },
            "indication": {
                "id": 10000003,
                "name": "Advanced Solid Tumor",
                "source": "JAX"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 3400,
                    "pubMedId": 21062981,
                    "title": "Global downstream pathway analysis reveals a dependence of oncogenic NF-E2-related factor 2 mutation on the mTOR growth signaling pathway.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21062981"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 10103,
            "profileName": "NFE2L2 T80R",
            "profileTreatmentApproaches": [
                
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 133974,
            "transcript": "NM_001313902",
            "gDna": "chr2:g.177234078G>C",
            "cDna": "c.239C>G",
            "protein": "p.T80R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 133976,
            "transcript": "NM_001313900",
            "gDna": "chr2:g.177234029_177234030delGGinsCC",
            "cDna": "c.239_240delCCinsGG",
            "protein": "p.T80R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 133978,
            "transcript": "NM_001145413",
            "gDna": "chr2:g.177234029_177234030delGGinsCC",
            "cDna": "c.239_240delCCinsGG",
            "protein": "p.T80R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 133975,
            "transcript": "NM_006164",
            "gDna": "chr2:g.177234078G>C",
            "cDna": "c.239C>G",
            "protein": "p.T80R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 133977,
            "transcript": "NM_001313901",
            "gDna": "chr2:g.177234029_177234030delGGinsCC",
            "cDna": "c.239_240delCCinsGG",
            "protein": "p.T80R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        },
        {
            "id": 133979,
            "transcript": "NM_001145412",
            "gDna": "chr2:g.177234029_177234030delGGinsCC",
            "cDna": "c.239_240delCCinsGG",
            "protein": "p.T80R",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}